Johnson & Johnson executive praises China's biotech innovation in oncology and immunology, highlighting potential future ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Biotech Showcase™ 2025 Opens the Year with ... These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. Plus, tired of market noise?

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...